Skip to main content
PNT logo

POINT Biopharma Global Inc. (PNT) Stock Analysis

DELISTED 2023

What happened to POINT Biopharma Global Inc. (PNT) stock?

POINT Biopharma Global Inc. (PNT) no longer trades on public markets. It was delisted in December 2023. The figures below are historical and are not a current quote.

Status:
Delisted — no longer trades
Delisting date:
December 2023
Last recorded price (historical):
$12.50 (last quote on record before the December 2023 delisting; historical, not a current quote)
MCap: $1.33B| P/E Ratio: 12.02| Vol: 3.29M| 52-wk range: $6.57 – $14.35

P/E 12.02 means the share price is 12.02 times one year of earnings per share. Market cap $1.33B is the value of all shares combined.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

POINT Biopharma Global Inc. (PNT). POINT Biopharma Global Inc. is a radiopharmaceutical company focused on developing and commercializing radioligands for cancer treatment. The company's lead product candidates target prostate cancer and neuroendocrine tumors, with ongoing Phase III trials.

Last analyzed: Mar 17, 2026
POINT Biopharma Global Inc. is a radiopharmaceutical company focused on developing and commercializing radioligands for cancer treatment. The company's lead product candidates target prostate cancer and neuroendocrine tumors, with ongoing Phase III trials.

POINT Biopharma Global Inc. (PNT) Healthcare & Pipeline Overview

Employees129
Model self-rating on this text: 82% (not a measure of the evidence) Updated: Mar 17, 2026

More about this archive record

Can I still buy PNT shares?

No. PNT stopped trading on public markets in December 2023, so the shares are not available through a broker. Anything you see quoted for PNT elsewhere is historical data, not a live market.

Are the figures on this page current?

No. Every number here is the last value recorded before PNT stopped trading. Nothing on this page updates, and none of it is a current quote.

Why does this page still exist?

Because people still search for what happened to POINT Biopharma Global Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. Last updated: .

Data provided for informational purposes only.